Omeprazole

Jump to

Aurobindo Pharma gets USFDA nod to market ulcer drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Omeprazole delayed-release capsules in the strengths of 10mg, 20mg and 40mg, Aurobindo Pharma said in a statement.
Bafna Pharmaceuticals gets nod from Ghana for Omeran-20

Bafna Pharmaceuticals has received approval from Ghana to market Omeran-20 capsules used for the treatment of reflux oesophagitis among others.
Espirito Santo Sec's health forecast for 3 pharma stocks

While the market has been weak, the pharma sector has remained steadfastly resilient. Chirag Talati, Pharma Analyst, Espirito Santo Securities talks about what is making news in the pharma space.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Omeprazole

Aurobindo Pharma gets USFDA nod to market ulcer drug

Bafna Pharmaceuticals gets nod from Ghana for Omeran-20

Espirito Santo Sec's health forecast for 3 pharma stocks